Companies GLAXO SMITHKLINE- PROD.FARMAC., LDA
Track this competitor Create a free account to be notified when it wins a contract.
Contracts won 7
Amount won alone €2,518,369 excl. VAT
Period 21 July 2026 – 6 October 2026
Where and what
Supplies · 7
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
Planned end Contract Current holder Amount
1 December 2026 re-tender around October 2026 2025/1589 - Dostarlimab [50 mg/ml 10 ml sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement GLAXO SMITHKLINE- PROD.FARMAC., LDA 1 bid received €336,635
4 December 2026 re-tender around October 2026 2023/0671 - Belimumab [200 mg/1ml sol inj caneta]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement GLAXO SMITHKLINE- PROD.FARMAC., LDA 1 bid received €87,692
28 December 2026 re-tender around October 2026 2024/0899 - Mepolizumab [100 mg/1 ml sol inj caneta]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement GLAXO SMITHKLINE- PROD.FARMAC., LDA 1 bid received €330,644
30 December 2026 re-tender around October 2026 2023/0671 - Belimumab [200 mg/1ml sol inj caneta]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement GLAXO SMITHKLINE- PROD.FARMAC., LDA 1 bid received €92,189
3 January 2027 re-tender around October 2026 2024/0899 - Mepolizumab [100 mg/1 ml sol inj caneta]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement GLAXO SMITHKLINE- PROD.FARMAC., LDA 1 bid received €235,408
5 January 2027 re-tender around October 2026 2024/0899 - Mepolizumab [100 mg/1 ml sol inj caneta]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement GLAXO SMITHKLINE- PROD.FARMAC., LDA 1 bid received €1,170,480
5 January 2027 re-tender around October 2026 2023/0671 - Belimumab [200 mg/1ml sol inj caneta]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement GLAXO SMITHKLINE- PROD.FARMAC., LDA 1 bid received €265,323
Contracts won
Date Contract Buyer Amount
06/10/2026
2025/1589 - Dostarlimab [50 mg/ml 10 ml sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €336,635
22/09/2026
2023/0671 - Belimumab [200 mg/1ml sol inj caneta] Unidade Local de Saúde Santa Maria, E.P.E. €87,692
22/09/2026
2023/0671 - Belimumab [200 mg/1ml sol inj caneta] Unidade Local de Saúde Santa Maria, E.P.E. €92,189
22/09/2026
2023/0671 - Belimumab [200 mg/1ml sol inj caneta] Unidade Local de Saúde Santa Maria, E.P.E. €265,323
21/07/2026
2024/0899 - Mepolizumab [100 mg/1 ml sol inj caneta] Unidade Local de Saúde Santa Maria, E.P.E. €1,170,480
21/07/2026
2024/0899 - Mepolizumab [100 mg/1 ml sol inj caneta] Unidade Local de Saúde Santa Maria, E.P.E. €235,408
21/07/2026
2024/0899 - Mepolizumab [100 mg/1 ml sol inj caneta] Unidade Local de Saúde Santa Maria, E.P.E. €330,644
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.
Publizoom